News & Updates

In the EMERALD-1 trial, durvalumab plus bevacizumab (D+B) combined with transarterial chemoembolization (TACE) improved progression-free survival (PFS) in individuals with unresectable hepatocellular carcinoma (HCC) eligible for embolization.

The presence of folic acid in plasma and intake of folic acid supplements appear to contribute to chemotherapy-induced toxicities in patients treated with capecitabine for colorectal cancer (CRC), reports a recent study.

Women who regularly consume dairy products do not have an increased risk of developing breast cancer, reveals a study. However, there is heterogeneity seen for the type of dairy food, period of life, and tumour subtypes.

Palliative-intent radiation was performed more frequently in patients with advanced nonsmall-cell lung cancer (NSCLC) and cachexia than those without weight loss. Unfortunately, tumour-directed therapy, whether in a curative or a palliative approach, proves inadequate in improving cachexia patient survival across all stages of the disease.